Clinical Trial

A Study of XS-02 Capsules in Patients With Advanced Solid Tumors

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A study to evaluate the safety, tolerability, Pharmacokinetics(pk), and efficacy of XS-02 capsules in patients with advanced solid tumors.
Trial Details
NCT Number NCT06531486
Lead Sponsor NovaOnco Therapeutics Co., Ltd.
Conditions Solid Tumor, Ovarian Cancer, Breast Cancer, Endometrial Cancer
Enrollment 96 participants
Start Date 2024-07-29
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-01